The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis

Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

(2017) Joanne L. Blum et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2017) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

(2016) Sean A. Virani et al.   CANADIAN JOURNAL OF CARDIOLOGY

Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study

(2016) J. Gavila et al.   Clinical & Translational Oncology

Chemotherapy-Induced Left Ventricular Dysfunction in Patients with Breast Cancer

(2016) Hyun Ju Yoon et al.   Journal of Breast Cancer

A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity

(2016) Paolo Spallarossa et al.   Journal of Cardiovascular Medicine

Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment

(2016) Sandy R. Truong et al.   ONCOLOGIST

Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients

(2015) Alain Mina et al.   BMC CANCER

Abstract P6-06-09: Baseline assessment of left ventricular function for breast cancer patients undergoing anthracycline and/or trastuzumab: What is the prevalence of baseline dysfunction?

(2014) MM Abu-Khalaf et al.   CANCER RESEARCH

Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection

(2013) K. Negishi et al.   European Heart Journal-Cardiovascular Imaging

Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

(2012) G. Curigliano et al.   ANNALS OF ONCOLOGY

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

(2012) E. J. A. Bowles et al.   JNCI-Journal of the National Cancer Institute

Routine Cardiac Evaluation in Patients With Early-Stage Breast Cancer Before Adjuvant Chemotherapy

(2011) Alwin Jeyakumar et al.   Clinical Breast Cancer